Evidence map›Paper›PMID 27213957›Full record

ArticlePLoS genetics2016

The Pilin N-terminal Domain Maintains Neisseria gonorrhoeae Transformation Competence during Pilus Phase Variation.

Kyle P Obergfell, H Steven Seifert

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Type IV pili ofEcoSal Plus · 2024
    Review
  8. Article
  9. Article
  10. Multisite transformation inFrontiers in microbiology · 2023
    Article
  11. Article
  12. Review
  13. Anti-Virulence Therapeutic Approaches forAntibiotics (Basel, Switzerland) · 2021
    Review
  14. Natural Competence and Horizontal Gene Transfer in Campylobacter.Current topics in microbiology and immunology · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. DNA Uptake by Type IV Filaments.Frontiers in molecular biosciences · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kyle P ObergfellDepartment of Microbiology-Immunology, Northwestern University's Feinberg School of Medicine, Chicago, Illinois, United States of America.ORCID 0000-0001-6395-3595
H Steven SeifertDepartment of Microbiology-Immunology, Northwestern University's Feinberg School of Medicine, Chicago, Illinois, United States of America.ORCID 0000-0001-8651-0375
Northwestern University · US

Funding

CELLULAR &MOLECULAR BASIS OF DISEASE TRAINING PROGRAMT32GM008061 · NIGMS · NORTHWESTERN UNIVERSITY · PI CARTHEW, RICHARD W. · 1985 to 2022
$17.1M
Mechanisms of Gonococcal Pilin Antigenic/Phase VariationR37AI033493 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Hank S. SEIFERT · 2003 to 2026
$10.1M
Molecular Genetics of the GonococcusR01AI044239 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SEIFERT, HANK S. · 1999 to 2014
$4.0M
Assembly and Function of the Gonococcal PilusR56AI114821 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SEIFERT, HANK S. · 2015 to 2015
$309k
NIAID NIH HHS R01 AI044239NIAID NIH HHS R37 AI033493NIAID NIH HHS R56 AI114821NIGMS NIH HHS T32 GM008061
6 · The paper itself

Abstract

The obligate human pathogen Neisseria gonorrhoeae is the sole aetiologic agent of the sexually transmitted infection, gonorrhea. Required for gonococcal infection, Type IV pili (Tfp) mediate many functions including adherence, twitching motility, defense against neutrophil killing, and natural transformation. Critical for immune escape, the gonococcal Tfp undergoes antigenic variation, a recombination event at the pilE locus that varies the surface exposed residues of the major pilus subunit PilE (pilin) in the pilus fiber. This programmed recombination system has the potential to produce thousands of pilin variants and can produce strains with unproductive pilin molecules that are completely unable to form Tfp. Saturating mutagenesis of the 3' third of the pilE gene identified 68 unique single nucleotide mutations that each resulted in an underpiliated colony morphology. Notably, all isolates, including those with undetectable levels of pilin protein and no observable surface-exposed pili, retained an intermediate level of transformation competence not exhibited in ΔpilE strains. Site-directed, nonsense mutations revealed that only the first 38 amino acids of the mature pilin N-terminus (the N-terminal domain or Ntd) are required for transformation competence, and microscopy, ELISAs and pilus purification demonstrate that extended Tfp are not required for competence. Transformation in strains producing only the pilin Ntd has the same genetic determinants as wild-type transformation. The Ntd corresponds to the alternative product of S-pilin cleavage, a specific proteolysis unique to pathogenic Neisseria. Mutation of the S-pilin cleavage site demonstrated that S-pilin cleavage mediated release of the Ntd is required for competence when a strain produces unproductive pilin molecules that cannot assemble into a Tfp through mutation or antigenic variation. We conclude that S-pilin cleavage evolved as a mechanism to maintain competence in nonpiliated antigenic variants and suggest there are alternate forms of the Tfp assembly apparatus that mediate various functions including transformation.

Indexed as

Codon, NonsenseCysteineFimbriae, BacterialFimbriae ProteinsGene Expression Regulation, BacterialGonorrheaHumansMutagenesisNeisseria gonorrhoeaeProtein DomainsTransformation, BacterialCodon, NonsenseCysteineFimbriae ProteinspilE protein, Neisseria gonorrhoeae

Identifiers

PMID27213957
PMCPMC4877100
OpenAlexW2408400537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.